Molecular allelokaryotyping of T-cell prolymphocytic leukemia cells with high density single nucleotide polymorphism arrays identifies novel common genomic lesions and acquired uniparental disomy

Haematologica

Volumn 94, Issue 4, 2009, Pages 518-527

  Nowak, Daniel ^a   Toriellec, Emilie Le ^b,c   Stern, Marc Henri ^b,c   Kawamata, Norihiko ^a   Akagi, Tadayuki ^a   Dyer, Martin J ^d   Hofmann, Wolf Karsten ^e   Ogawa, Seishi ^f,g,h   Koeffler, H Phillip ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INSTITUT CURIE   (France)

^c INSTITUT CURIE   (France)

^d University Hospitals   (United Kingdom)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f GRADUATE SCHOOL OF MEDICINE   (Japan)

^g JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^h UNIVERSITY OF TOKYO   (Japan)

Author keywords

Copy number change; Snp array; T cell prolymphocytic leukemia; Uniparental disomy

Indexed keywords

GENOMIC DNA; MICRORNA; NIBRIN; PLECKSTRIN; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR FLI 1;

ARTICLE; CHROMOSOME 11; CHROMOSOME 11Q; CHROMOSOME 12P; CHROMOSOME 13P; CHROMOSOME 14; CHROMOSOME 17; CHROMOSOME 17Q; CHROMOSOME 22; CHROMOSOME 5; CHROMOSOME 8; CHROMOSOME 8P; CHROMOSOME 8Q; CHROMOSOME BREAKAGE; CHROMOSOME DAMAGE; CHROMOSOME DELETION; CHROMOSOME INVERSION; CHROMOSOME MUTATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; GENE; GENE IDENTIFICATION; GENE SEQUENCE; HISTONE ACETYLTRANSFERASE MONOCYTIC GENE; HUMAN; KARYOTYPING; LEUKEMIA CELL; NEPHROBLASTOMA OVEREXPRESSED PRECURSOR GENE; NUCLEOTIDE SEQUENCE; PROLYMPHOCYTIC LEUKEMIA; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; UNIPARENTAL DISOMY;

ALLELES; CHROMOSOME ABERRATIONS; DNA MUTATIONAL ANALYSIS; HUMANS; KARYOTYPING; LEUKEMIA, PROLYMPHOCYTIC, T-CELL; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; UNIPARENTAL DISOMY;

EID: 66349108455     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2008.001347     Document Type: Article

References (48)

1. Dearden CE. T-cell prolymphocytic leukemia. Med Oncol 2006;23:17-22.
2. Dearden CE, Matutes E, Cazin B, Tjonnfjord GE, Parreira A, Nomdedeu B, et al. High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H. Blood 2001;98:1721-6.
3. Keating MJ, Cazin B, Coutre S, Birhiray R, Kovacsovics T, Langer W, et al. Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failed. J Clin Oncol 2002;20:205-13.
4. Pekarsky Y, Hallas C, Croce CM. Molecular basis of mature T-cell leukemia. JAMA 2001;286:2308-14.
5. Stern MH, Soulier J, Rosenzwajg M, Nakahara K, Canki-Klain N, Aurias A, et al. MTCP-1: a novel gene on the human chromosome Xq28 translo- cated to the T cell receptor alpha/delta locus in mature T cell pro- liferations. Oncogene 1993;8:2475-83.
6. Stankovic T, Taylor AM, Yuille MR, Vorechovsky I. Recurrent ATM muta- tions in T-PLL on diverse haplotypes: no support for their germline origin. Blood 2001;97:1517-8.
7. Stilgenbauer S, Schaffner C, Litterst A, Liebisch P, Gilad S, Bar-Shira A, et al. Biallelic mutations in the ATM gene in T-prolymphocytic leukemia. Nat Med 1997;3:1155-9.
8. Maljaei SH, Brito-Babapulle V, Hiorns LR, Catovsky D. Abnormalities of chromosomes 8, 11, 14, and X in T- prolymphocytic leukemia studied by fluorescence in situ hybridization. Cancer Genet Cytogenet 1998;103: 110-6.
9. Sorour A, Brito-Babapulle V, Smedley D, Yuille M, Catovsky D. Unusual breakpoint distribution of 8p abnor- malities in T-prolymphocytic leukemia: a study with YACS map- ping to 8p11-p12. Cancer Genet Cytogenet 2000;121:128-32.
10. Stoppa-Lyonnet D, Soulier J, Lauge A, Dastot H, Garand R, Sigaux F, et al. Inactivation of the ATM gene in T- cell prolymphocytic leukemias. Blood 1998;91:3920-6.
11. Stoppa-Lyonnet D, Lauge A, Sigaux F, Stern MH. No germline ATM muta- tion in a series of 16 T-cell prolym- phocytic leukemias. Blood 2000;96: 374-6.
12. Teitell MA. The TCL1 family of oncoproteins: co-activators of trans- formation. Nat Rev Cancer 2005;5: 640-8.
13. Despouy G, Joiner M, Le Toriellec E, Weil R, Stern MH. The TCL1 onco- protein inhibits activation-induced cell death by impairing PKCtheta and ERK pathways. Blood 2007;110: 4406-16.
14. Herling M, Patel KA, Teitell MA, Konopleva M, Ravandi F, Kobayashi R, et al. High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia. Blood 2008;111:328-37.
15. Shiloh Y. Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart. Annu Rev Genet 1997;31:635-62.
16. Lavin MF. ATM and the Mre11 com- plex combine to recognize and signal DNA double-strand breaks. Oncogene 2007;26:7749-58.
17. Lee JH, Paull TT. Activation and regu- lation of ATM kinase activity in response to DNA double-strand breaks. Oncogene 2007;26:7741-8.
18. Durig J, Bug S, Klein-Hitpass L, Boes T, Jons T, Martin-Subero JI, et al. Combined single nucleotide poly- morphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbal- ances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q11q32). Leukemia 2007;21:2153-63.
19. Le Toriellec E, Despouy G, Pierron G, Gaye N, Joiner M, Bellanger D, et al. Haploinsufficiency of CDKN1B con- tributes to leukemogenesis in T-cell prolymphocytic leukemia. Blood 2008;111:2321-8.
20. Dutt A, Beroukhim R. Single nucleotide polymorphism array analysis of cancer. Curr Opin Oncol 2007;19:43-9.
21. Yamamoto G, Nannya Y, Kato M, Sanada M, Levine RL, Kawamata N, et al. Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of Affymetrix single-nucleotide-poly- morphism genotyping microarrays. Am J Hum Genet 2007;81:114-26.
22. Nannya Y, Sanada M, Nakazaki K, Hosoya N, Wang L, Hangaishi A, et al. A robust algorithm for copy num- ber detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. Cancer Res 2005;65:6071-9.
23. Weksberg R, Hughes S, Moldovan L, Bassett AS, Chow EW, Squire JA. A method for accurate detection of genomic microdeletions using real- time quantitative PCR. BMC Genomics 2005;6:180.
24. Soulier J, Pierron G, Vecchione D, Garand R, Brizard F, Sigaux F, et al. A complex pattern of recurrent chro- mosomal losses and gains in T-cell prolymphocytic leukemia. Genes Chromosomes Cancer 2001;31:248-54.
25. Kobayashi H, Montgomery KT, Bohlander SK, Adra CN, Lim BL, Kucherlapati RS, et al. Fluorescence in situ hybridization mapping of translocations and deletions involv- ing the short arm of human chromo- some 12 in malignant hematologic diseases. Blood 1994;84:3473-82.
26. Bohlander SK. ETV6: a versatile play- er in leukemogenesis. Semin Cancer Biol 2005;15:162-74.
27. Kawamata N, Ogawa S, Zimmermann M, Kato M, Sanada M, Hemminki K, et al. Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high- resolution single nucleotide poly- morphism oligonucleotide genomic microarray. Blood 2008;111:776-84.
28. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and down-regula- tion of micro- RNA genes miR15 and miR16 at 13q14 in chronic lympho- cytic leukemia. Proc Natl Acad Sci USA 2002;99:15524-9.
29. Calin GA, Cimmino A, Fabbri M, Ferracin M, Wojcik SE, Shimizu M, et al. MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci USA 2008;105:5166-71.
30. Constantinescu SN, Girardot M, Pecquet C. Mining for JAK-STAT mutations in cancer. Trends Biochem Sci 2008;33:122-31.
31. Lehmann S, Ogawa S, Raynaud SD, Sanada M, Nannya Y, Ticchioni M, et al. Molecular allelokaryotyping of early-stage, untreated chronic lym- phocytic leukemia. Cancer 2008;112: 1296-305.
32. Allam A, Marshall AJ. Role of the adaptor proteins Bam32, TAPP1 and TAPP2 in lymphocyte activation. Immunol Lett 2005;97:7-17.
33. Gupta R, Hong D, Iborra F, Sarno S, Enver T. NOV (CCN3) functions as a regulator of human hematopoietic stem or progenitor cells. Science 2007;316:590-3.
34. Troke PJ, Kindle KB, Collins HM, Heery DM. MOZ fusion proteins in acute myeloid leukaemia. Biochem Soc Symp 2006:23-39.
35. Hermeking H. p53 enters the microRNA world. Cancer Cell 2007; 12:414-8.
36. Welch C, Chen Y, Stallings RL. MicroRNA-34a functions as a poten- tial tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 2007;26:5017-22.
37. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apop- tosis. Mol Cell 2007;26:745-52.
38. Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R, Love RE, et al. p53-mediated activation of miRNA34 candidate tumor-suppres- sor genes. Curr Biol 2007;17:1298-307.
39. Dittmer J. The biology of the Ets1 proto-oncogene. Mol Cancer 2003; 2:29.
40. Truong AH, Ben-David Y. The role of Fli-1 in normal cell function and malignant transformation. Oncogene 2000;19:6482-9.
41. Koon HB, Ippolito GC, Banham AH, Tucker PW. FOXP1: a potential ther- apeutic target in cancer. Expert Opin Ther Targets 2007;11:955-65.
42. Fox SB, Brown P, Han C, Ashe S, Leek RD, Harris AL, et al. Expression of the forkhead transcription factor FOXP1 is associated with estrogen receptor α and improved survival in primary human breast carcinomas. Clin Cancer Res 2004;10:3521-7.
43. Du MQ. MALT lymphoma: recent advances in aetiology and molecular genetics. J Clin Exp Hematop 2007; 47:31-42.
44. Kawamata N, Ogawa S, Zimmermann M, Niebuhr B, Stocking C, Sanada M, et al. Cloning of genes involved in chromosomal translocations by high-resolution sin- gle nucleotide polymorphism genomic microarray. Proc Natl Acad Sci USA 2008;105:11921-6.
45. Bredemeyer AL, Huang CY, Walker LM, Bassing CH, Sleckman BP. Aberrant V(D)J recombination in ataxia telangiectasia mutated-defi- cient lymphocytes is dependent on nonhomologous DNA end joining. J Immunol 2008;181:2620-5.
46. Mullighan CG, Miller CB, Radtke I, Phillips LA, Dalton J, Ma J, et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 2008;453:110-4.
47. Zenz T, Dohner H, Stilgenbauer S. Genetics and risk-stratified approach to therapy in chronic lymphocytic leukemia. Best Pract Res Clin Haematol 2007;20:439-53.
48. Robinson WP. Mechanisms leading to uniparental disomy and their clin- ical consequences. Bioessays 2000;22: 452-9.